Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide Challenge. Medical University of South Carolina, Charleston, South Carolina-Reference-Cited by-同舟云学术

Phase I Study of Recombinant CEA Vaccinia Virus Vaccine with Post Vaccination CEA Peptide Challenge. Medical University of South Carolina, Charleston, South Carolina

Published:1996-07-10 Issue:11 Volume:7 Page:1381-1394
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Cole David J.¹,Wilson Michael C.¹,Baron Paul L.¹,O'Brien Paul¹,Reed Carolyn²,Tsang Kwong Y.²,Schlom Jeffrey²,Cole David J.³

Affiliation:

1. MUSC Dept. of Surgery and Hollings Cancer Center, Charleston, South Carolina

2. Laboratory of Tumor Immunology and Biology, NCI/DBS, Bethesda, MD

3. MUSC Dept. of Surgery, Room 420N CSB 171 Ashley Ave., Charleston, South Carolina, 29425, ph. (803) 792-3276, FAX (803) 792-2048

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1996.7.11-1381

Reference35 articles.

1. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

2. Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

3. Cancer statistics, 1992

4. Safety of recombinant vaccinia vaccines

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic viruses: a new class of immunotherapy drugs;Nature Reviews Drug Discovery;2015-09

2. Library screening and receptor-directed targeting of gammaretroviral vectors;Future Microbiology;2013-01

3. Vaccines for Pancreatic Cancer;The Cancer Journal;2012-11

4. Applications of Gene Therapy;Challenges in Delivery of Therapeutic Genomics and Proteomics;2011

5. Clinical development of MVA-based therapeutic cancer vaccines;Expert Review of Vaccines;2008-09